Literature DB >> 35261696

Acute decompensated heart failure in a patient with primary aldosteronism successfully treated with an adrenalectomy: A case report.

Yasutaka Imamura1, Atsushi Suzuki1, Michiru Nomoto1, Mayu Takano1, Shintaro Sawa2, Ryogo Hoki2, Noriko Kikuchi1, Yusaku Yoshida3, Kenta Uto4, Hiroshi Niinami2, Nobuhisa Hagiwara1.   

Abstract

Primary aldosteronism is often associated with heart failure (HF), and is reportedly difficult to treat in some cases. We report a case of severe HF associated with primary aldosteronism. A patient with HF, who was suspected of having primary aldosteronism, was referred to and examined at our hospital. After detailed examination, the patient was diagnosed with exacerbation of HF, and was treated at our department. Catheterization after admission revealed Forrester class IV HF. The patient was treated with catecholamine infusion in combination with medical treatment including mineralocorticoid receptor antagonists. The patient was diagnosed with hypertension due to primary aldosteronism and intractable secondary HF with increased peripheral vascular resistance. An open adrenalectomy was successfully performed under intra-aortic balloon pumping. Right heart catheterization, performed soon thereafter, demonstrated improvement in the patient's blood pressure and hemodynamics. We speculate that the improved cardiac function resulted from a reduction in the vascular resistance, as a consequence of the adrenalectomy. <Learning objective: Acute decompensated heart failure (HF) is one of the cardiovascular complications in patients with primary aldosteronism. However, there are few reports on the effective management of severe HF with concomitant primary aldosteronism. Although the appropriate time-frame for performing adrenalectomy remains undetermined, the procedure may effectively improve hemodynamics of patients with primary aldosteronism; this facilitates treatment of severe HF.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute decompensated heart failure; Adrenalectomy; Catecholamine; Primary aldosteronism

Year:  2021        PMID: 35261696      PMCID: PMC8888726          DOI: 10.1016/j.jccase.2021.08.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure.

Authors:  Aurelie Nguyen Dinh Cat; Violaine Griol-Charhbili; Laurent Loufrani; Carlos Labat; Laura Benjamin; Nicolette Farman; Patrick Lacolley; Daniel Henrion; Frederic Jaisser
Journal:  FASEB J       Date:  2010-03-18       Impact factor: 5.191

2.  Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?

Authors:  S Morimoto; R Takeda; M Murakami
Journal:  J Clin Endocrinol Metab       Date:  1970-12       Impact factor: 5.958

3.  Observational study mortality in treated primary aldosteronism: the German Conn's registry.

Authors:  Martin Reincke; Evelyn Fischer; Sabine Gerum; Katrin Merkle; Sebastian Schulz; Anna Pallauf; Marcus Quinkler; Gregor Hanslik; Katharina Lang; Stefanie Hahner; Bruno Allolio; Christa Meisinger; Rolf Holle; Felix Beuschlein; Martin Bidlingmaier; Stephan Endres
Journal:  Hypertension       Date:  2012-07-23       Impact factor: 10.190

4.  Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.

Authors:  Youichi Ohno; Masakatsu Sone; Nobuya Inagaki; Toshinari Yamasaki; Osamu Ogawa; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Hironobu Umakoshi; Mika Tsuiki; Takamasa Ichijo; Takuyuki Katabami; Yasushi Tanaka; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Katsutoshi Takahashi; Megumi Fujita; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Yuichi Fujii; Koichi Yamamoto; Atsushi Ogo; Shintaro Okamura; Shozo Miyauchi; Tomikazu Fukuoka; Shoichiro Izawa; Takashi Yoneda; Shigeatsu Hashimoto; Toshihiko Yanase; Tomoko Suzuki; Takashi Kawamura; Yasuharu Tabara; Fumihiko Matsuda; Mitsuhide Naruse
Journal:  Hypertension       Date:  2018-01-22       Impact factor: 10.190

5.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

Review 6.  Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension.

Authors:  K T Weber; J S Janicki; R Pick; J Capasso; P Anversa
Journal:  Am J Cardiol       Date:  1990-04-03       Impact factor: 2.778

7.  Improvement of Cardiac Function by Laparoscopic Adrenalectomy in a Patient with Severe Heart Failure Attributable to Primary Aldosteronism.

Authors:  Shin Sato; Yoshihide Kawasaki; Akihiro Ito; Ryo Morimoto; Shuichi Shimada; Takuma Sato; Hideaki Izumi; Naoki Kawamorita; Shinichi Yamashita; Koji Mitsuzuka; Yoichi Arai
Journal:  Tohoku J Exp Med       Date:  2019-05       Impact factor: 1.848

8.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

9.  Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.

Authors:  Suguru Yasuoka; Hisashi Kai; Hidemi Kajimoto; Hiroshi Kudo; Narimasa Takayama; Takahiro Anegawa; Mitsuhisa Koga; Takanobu Miyamoto; Hiroharu Mifune; Masayoshi Kage; Yoshitaka Hirooka; Tsutomu Imaizumi
Journal:  Circ J       Date:  2013-03-07       Impact factor: 2.993

10.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

Authors:  E Born-Frontsberg; M Reincke; L C Rump; S Hahner; S Diederich; R Lorenz; B Allolio; J Seufert; C Schirpenbach; F Beuschlein; M Bidlingmaier; S Endres; M Quinkler
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.